Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 20, 2024 8:15pm
Avenanthramide
What happened to avenanthramide sales? One possibility is that the amount if avenanthramide was changed after the spin-off from J&J. This could create an opportunity for Juvente. Perplexity Ai
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 20, 2024 7:29pm
RE:RE:RE:Email to Gilles Gagnon on March 7, 2024
Oats, we were told prior to any "merger" activtiy that Ceapro had adequate funds to prioritize it's projects with cash on hand. If AV sales which we said to rebound did occur then cash
...more
BioVaxys Partner SpayVac for Wildlife, Inc., Scales-Up Vaccine Production Capacity
posted Nov 20, 2024 9:00am by
BioVaxys Technology Corp.
-
|
Kenneth Kovan, BioVaxys President & Chief Operating Officer, stated, "SpayVac for Wildlife, already a leader in developing breeding control, will leverage its scaled-up capacity to shorten the product-development cycle allowing them to further expand their pipeline using BioVaxys' technology platforms as engines for ...read more
(11)
•••
oats
X
View Profile
View Bullboard History
Comment by
oats
on Nov 20, 2024 7:04pm
RE:RE:Email to Gilles Gagnon on March 7, 2024
That is easy Ciao. They pissed away so much money on legal fees prior to announcing the deal, lower sales, and initiative $$ requirements were decimating the cash level of the company. Based on
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 20, 2024 6:19pm
RE:Email to Gilles Gagnon on March 7, 2024
Oats, thanks for sharing your thoughts in this email to Gilles. I'll let you decide if you want to share any details for your statement with regards to the merger "You forced the hand of my
...more
(11)
•••
oats
X
View Profile
View Bullboard History
Post by
oats
on Nov 20, 2024 5:42pm
Email to Gilles Gagnon on March 7, 2024
If you are interested in my exact thoughts on the Merger, please see below for the message sent to Gilles on March 7, 2024. I will post the response that I got tomorrow. Hi Gilles, As
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Nov 20, 2024 7:36am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Cash
Yes that was in 02/2021 where they also forecasted 2 market launches within 18 months as well as estimating the immune booster market would see 40 % annuel increase until 2030 due to
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Nov 19, 2024 5:52pm
RE:RE:RE:RE:RE:RE:RE:RE:Cash
They've provided a net present value analysis previously for a 40 million dose immune booster plant.
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Nov 19, 2024 2:51pm
RE:RE:RE:RE:RE:RE:RE:RE:Cash
I was going to say the same thing ... complete a 2 year merger with no planning ...
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Nov 19, 2024 2:23pm
RE:RE:RE:RE:RE:RE:RE:Cash
It is unlikely to see a forward business plan Tge function of business planning , forecasting does not exist on the current Leadership Team
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Nov 19, 2024 9:01am
RE:RE:RE:RE:RE:RE:Cash
"This company needs a quick 360 degress change of attitude for any chance of success. You would need a new CEO who brings in new ambitions, new way of seing the company, new money, new
...more
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Comment by
jrsloan60
on Nov 18, 2024 2:49pm
RE:RE:RE:RE:RE:RE:RE:Cash
Well said I'm not much of a writer but I believe believed that we had a company that made cash flow and had potential for long-term growth. Maybe not fast and that's what I thought I was in. I
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 18, 2024 8:05am
RE:RE:RE:RE:RE:RE:Cash
Unless you have a seat on the board you won't be effective. Oats had an opportunity to vote Gilles off the board a few years ago and to vote no to the merger last year. He was told to tune out
...more
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Nov 17, 2024 2:45pm
RE:RE:RE:RE:RE:Cash
There is a main problem with the next CEO, if he is placed there by Gagnon or Gagnon and friends, there is a high chance he will be a puppet with no real power for change. This company needs a
...more
(295)
•••
Tropicalsun
X
View Profile
View Bullboard History
Comment by
Tropicalsun
on Nov 17, 2024 9:27am
RE:RE:RE:RE:Cash
Tencents, there many shareholders here that never agreed to or wanted this merger. The fact is that it is a done deal, I would suggest you stop looking in rear view mirror and look to the future of
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Nov 16, 2024 12:30pm
RE:RE:RE:Cash
Seems there is 12 months ot more cash indeed cash should be around 12 m mid 2025 Which is what czs brought to the merger and czo has probably been break even cash since The PR indicated the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden